Free Trial
NASDAQ:ISPC

iSpecimen (ISPC) Stock Price, News & Analysis

iSpecimen logo
$1.26 -0.02 (-1.17%)
Closing price 05/2/2025 03:58 PM Eastern
Extended Trading
$1.20 -0.06 (-5.14%)
As of 05/2/2025 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iSpecimen Stock (NASDAQ:ISPC)

Key Stats

Today's Range
$1.25
$1.30
50-Day Range
$1.06
$1.83
52-Week Range
$1.02
$11.80
Volume
20,410 shs
Average Volume
414,210 shs
Market Capitalization
$3.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

iSpecimen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

ISPC MarketRank™: 

iSpecimen scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for iSpecimen.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iSpecimen is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iSpecimen is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    iSpecimen has a P/B Ratio of 0.06. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about iSpecimen's valuation and earnings.
  • Percentage of Shares Shorted

    2.70% of the float of iSpecimen has been sold short.
  • Short Interest Ratio / Days to Cover

    iSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iSpecimen has recently increased by 65.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iSpecimen does not currently pay a dividend.

  • Dividend Growth

    iSpecimen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.70% of the float of iSpecimen has been sold short.
  • Short Interest Ratio / Days to Cover

    iSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iSpecimen has recently increased by 65.62%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    iSpecimen has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • Search Interest

    Only 1 people have searched for ISPC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iSpecimen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.20% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 13.62% of the stock of iSpecimen is held by institutions.

  • Read more about iSpecimen's insider trading history.
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Stock News Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
iSpecimen Shares Rise After Securring Virus Suppliers
iSpecimen Appoints Robert Lim as New CEO
iSpecimen Inc. Reports Earnings Amid Financial Challenges
See More Headlines

ISPC Stock Analysis - Frequently Asked Questions

iSpecimen's stock was trading at $2.65 at the beginning of the year. Since then, ISPC stock has decreased by 52.3% and is now trading at $1.2650.
View the best growth stocks for 2025 here
.

iSpecimen Inc. (NASDAQ:ISPC) issued its earnings results on Monday, April, 14th. The company reported ($6.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.00) by $2.28. The business earned $1.48 million during the quarter, compared to the consensus estimate of $2.98 million. iSpecimen had a negative net margin of 91.66% and a negative trailing twelve-month return on equity of 139.25%.

iSpecimen (ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at a price of $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iSpecimen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and Braze (BRZE).

Company Calendar

Last Earnings
4/14/2025
Today
5/03/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Commercial physical research
Sub-Industry
Business Services
Current Symbol
NASDAQ:ISPC
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-11,100,000.00
Pretax Margin
-91.65%

Debt

Sales & Book Value

Annual Sales
$9.29 million
Price / Cash Flow
N/A
Book Value
$21.47 per share
Price / Book
0.06

Miscellaneous

Free Float
846,000
Market Cap
$3.16 million
Optionable
Not Optionable
Beta
1.77
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:ISPC) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners